Author |
Title |
Year |
Publication |
Volume |
Pages |
Vidaurre, T.; Santos, C.; Gomez, H.; Sarria, G.; Amorin, E.; Lopez, M.; Regalado, R.; Manrique, J.; Tarco, D.; Ayestas, C.; Calderon, M.; Mas, L.; Neciosup, S.; Salazar, M.; Chavez, J.C.; Ubillus, M.; Limache, A.; Ubillus, J.C.; Navarro, J.; Sarwal, K.; Sutcliffe, S.; Gutierrez-Aguado, A.; Silva, M.; Mena, A.; Guillen, M.E.; Castaneda, C.; Abugattas, J. |
The implementation of the Plan Esperanza and response to the imPACT Review |
2017 |
The Lancet. Oncology |
18 |
e595-e606 |
Brinkmann, S. |
“Fight the poisoners of the people!” The beginnings of food regulation in Sao Paulo and Rio de Janeiro, 1889-1930 |
2017 |
Historia, Ciencias, Saude--Manguinhos |
24 |
313-331 |
Brown, D.V.; Filiz, G.; Daniel, P.M.; Hollande, F.; Dworkin, S.; Amiridis, S.; Kountouri, N.; Ng, W.; Morokoff, A.P.; Mantamadiotis, T. |
Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity |
2017 |
PloS one |
12 |
e0172791 |
Guerrero, P.A.; Tchaicha, J.H.; Chen, Z.; Morales, J.E.; McCarty, N.; Wang, Q.; Sulman, E.P.; Fuller, G.; Lang, F.F.; Rao, G.; McCarty, J.H. |
Glioblastoma stem cells exploit the alphavbeta8 integrin-TGFbeta1 signaling axis to drive tumor initiation and progression |
2017 |
Oncogene |
|
|
Jin, W.-L.; Mao, X.-Y.; Qiu, G.-Z. |
Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges |
2017 |
Medicinal Research Reviews |
37 |
627-661 |